Back to Results
First PageMeta Content
Cancer organizations / Immunotherapy / Melanoma / Cancer immunotherapy / Cancer research / Ipilimumab / Prostate cancer / Cancer vaccine / James L. Gulley / Medicine / Cancer treatments / Immunology


MD Anderson, MedImmune join forces on immunotherapy Friday, March 14, 2014 Jim Allison, Ph.D., is executive director of the immunotherapy platform. MD Anderson and MedImmune, the global biologics research and development
Add to Reading List

Document Date: 2015-05-09 06:45:52


Open Document

File Size: 240,13 KB

Share Result on Facebook
UPDATE